Page 30 - SPEMD_58-4
P. 30

218                    rev port estomatol med dent cir maxilofac. 2017;58(4):212-218


            4. Diz P, Scully C, Sanz M. Dental implants in the medically   17. Binon PP. Thirteen-year follow-up of a mandibular implant-
             compromised patient. J Dent. 2013;41:195-206.       supported fixed complete denture in a patient with Sjögren’s
            5. Alsaadi G, Quirynen M, Komárek A, van Steenberghe D.   syndrome: a clinical report. J Prosthet Dent. 2005;94:409-13.
             Impact of local and systemic factors on the incidence of late   18. Isidor F, Brøndum K, Hansen HJ, Jensen J, Sindet-Pedersen S.
             oral implant loss. Clin Oral Implants Res. 2008;19:670-6.  Outcome of treatment with implant-retained dental
            6. Mombelli A, Cionca N. Systemic diseases affecting   prostheses in patients with Sjögren syndrome. Int J Oral
             osseointegration therapy. Clin Oral Implants Res. 2006;17:97-103.  Maxillofac Implants. 1999;14:736-43.
            7. Amerongen AV, Veerman EC. Saliva – the defender of the oral   19. Payne AG, Lownie JF, Van Der Linden WJ. Implant-supported
             cavity. Oral Dis. 2002;8:12-22.                     prostheses in patients with Sjögren’s syndrome: a clinical
            8. Epstein JBDC. Villines and H.Y. Sroussi. Oral symptoms and   report on three patients. Int J Oral Maxillofac Implants.
             oral function in people with Sjögren’s syndrome. Clin Exp   1997;12:679-85.
             Rheumatol. 2015;33:132-3.                        20. World Health Organization. Oral Health Surveys: Basic
                                                                         rd
            9. Donaldson MJ. Epstein and D. Villines. Managing the care of   methods. 3  ed. Genebra: WHO, 1997.
             patients with Sjögren syndrome and xerostomia:   21. Beck JD, Löe H Epidemiological principles in studying
             comorbidities medication use and dental care        periodontal diseases. Periodontol 2000. 1993;2:34-45.
             considerations. J Am Dent Assoc. 2014;145:1240-7.  22. Navazesh M, Kumar SK. Measuring salivary flow: challenges
           10. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria   and opportunities. J Am Dent Assoc. 2008;139(Suppl):35S-40S.
             for Sjögren’s syndrome: a revised version of the European   23. Thomson WM. Measuring change in dry-mouth symptoms
             criteria proposed by the American-European Consensus   over time using the Xerostomia Inventory. Gerodontology.
             Group. Ann Rheum Dis. 2002;61:554-8.                2007;24:30-5.
           11. Pereira R, Amaral J, Marques D, Barcelos F, Patto JV, Mata A.   24. Montero-Martín J. Bravo-Pérez M. Albaladejo-Martínez A.
             Qualidade de vida oral e sistémica na Síndrome de Sjögren   Hernández-Martín LA. Rosel-Gallardo EM. Validation the Oral
             Primária. Rev Port Estomatol Med Dent Cir Maxilofac.   Health Impact Profile (OHIP-14sp) for adults in Spain. Med
             2017;58:97-104.                                     Oral Patol Oral Cir Bucal. 2009;14:E44-50.
           12. Bolstad AI, Skarstein K. Epidemiology of Sjögren’s Syndrome   25. Krennmair G, Seemann R, Piehslinger E. Dental implants in
             – from an Oral Perspective. Curr Oral Health Rep. 2016; 328-36.  patients with rheumatoid arthritis: clinical outcome and
           13. Le Gall M, Cornec D, Pers JO et al. A prospective evaluation of   peri-implant findings. J Clin Periodontol. 2010;37:928-36.
             dental and periodontal status in patients with suspected   26. Korfage A, Raghoebar GM, Arends S et al. Dental implants in
             Sjögren’s syndrome. Joint Bone Spine. 2016;83:235-6.  patients with Sjögren’s syndrome. Clin Implant Dent Relat
           14. Antoniazzi RP, Miranda LA, Zanatta FB et al. Periodontal   Res. 2015;18:937-45.
             conditions of individuals with Sjögren’s syndrome. J   27. Albrecht K, Callhoff J, Westhoff G, Dietrich T, Dörner T, Zink A.
             Periodontol. 2009;80:429-35.                        The prevalence of dental implants and related factors in
           15. Reichart PA, Schmidt-Westhausen AM, Khongkhunthian P,   patients with Sjögren syndrome: results from a cohort study.
             Strietzel FP. Dental implants in patients with oral mucosal   J Rheumatol. 2016;43:1380-5.
             diseases – a systematic review. J Oral Rehabil. 2016;43:388-99.  28. Kuoppala R, Näpänkangas R, Raustia A. Quality of life of
           16. Candel-Marti ME, Ata-Ali J, Peñarrocha-Oltra D, Peñarrocha-  patients treated with implant-supported mandibular
             Diago MA, Bagán JV. Dental implants in patients with oral   overdentures evaluated with the oral health impact profile
             mucosal alterations: an update. Med Oral Patol Oral Cir   (OHIP-14): a survey of 58 patients. J Oral Maxillofac Res.
             Bucal. 2011;16:e787-93.                             2013;4:e4.
   25   26   27   28   29   30   31   32   33   34   35